Bearish
TPST Stock Plummets After Inking Deal To Acquire CAR-T Programs From Privately-Held Firm In All-Stock Transaction
Tempest Therapeutics' stock (TPST) crashed following its announcement to acquire two preclinical CAR-T programs from a privately held biotechnology co...